🇺🇸 FDA
Patent

US 10710989

Method for producing heterocyclic compound

granted A61KA61K31/4155A61P

Quick answer

US patent 10710989 (Method for producing heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/4155, A61P, A61P25/28